211 related articles for article (PubMed ID: 19907807)
1. Dabigatran: safer, more effective and easier to use than warfarin.
Cardiovasc J Afr; 2009; 20(5):311-2. PubMed ID: 19907807
[No Abstract] [Full Text] [Related]
2. Quality of anticoagulation control in atrial fibrillation.
Lane DA; Lip GY
Lancet; 2010 Sep; 376(9745):935-7. PubMed ID: 20801499
[No Abstract] [Full Text] [Related]
3. Dabigatran in clinical practice.
Nagarakanti R; Ellis CR
Clin Ther; 2012 Oct; 34(10):2051-60. PubMed ID: 23031622
[TBL] [Abstract][Full Text] [Related]
4. Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary.
Waks JW; Zimetbaum PJ
Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1461-71. PubMed ID: 24147516
[TBL] [Abstract][Full Text] [Related]
5. The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation.
Amorosi SL; Armstrong S; Da Deppo L; Garfield S; Stein K
Europace; 2014 Aug; 16(8):1131-6. PubMed ID: 24687964
[TBL] [Abstract][Full Text] [Related]
6. Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation.
Belavic JM
Nurse Pract; 2011 Sep; 36(9):6-7. PubMed ID: 21857210
[No Abstract] [Full Text] [Related]
7. Home-monitoring of oral anticoagulation vs. dabigatran. An indirect comparison.
Alonso-Coello P; Zhou Q; Guyatt G
Thromb Haemost; 2012 Oct; 108(4):647-53. PubMed ID: 22918481
[TBL] [Abstract][Full Text] [Related]
8. Can we rely on RE-LY?
Gage BF
N Engl J Med; 2009 Sep; 361(12):1200-2. PubMed ID: 19717843
[No Abstract] [Full Text] [Related]
9. Dabigatran versus warfarin for patients with non-valvular atrial fibrillation: is the patient the winner?
Grave S
Aust Nurs J; 2011 Dec-2012 Jan; 19(6):30-3. PubMed ID: 22329103
[TBL] [Abstract][Full Text] [Related]
10. Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves.
Carnicelli AP; De Caterina R; Halperin JL; Renda G; Ruff CT; Trevisan M; Nordio F; Mercuri MF; Antman E; Giugliano RP;
Circulation; 2017 Mar; 135(13):1273-1275. PubMed ID: 28209729
[No Abstract] [Full Text] [Related]
11. Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
Bin Abdulhak AA; Khan AR; Tleyjeh IM; Spertus JA; Sanders SU; Steigerwalt KE; Garbati MA; Bahmaid RA; Wimmer AP
Europace; 2013 Oct; 15(10):1412-20. PubMed ID: 23954918
[TBL] [Abstract][Full Text] [Related]
12. [Atrial fibrillation: novel possibilities of anticoagulant therapy in patients subjected to cardioversion].
Averkov OV
Kardiologiia; 2011; 51(7):53-7. PubMed ID: 21878086
[No Abstract] [Full Text] [Related]
13. NICE backs new oral anticoagulant for stroke prevention.
Wise J
BMJ; 2012 Mar; 344():e2111. PubMed ID: 22427274
[No Abstract] [Full Text] [Related]
14. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
Lip GY; Larsen TB; Skjøth F; Rasmussen LH
J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
[TBL] [Abstract][Full Text] [Related]
15. Lessons from the RE-ALIGN trial.
Iung B; Vahanian A
Arch Cardiovasc Dis; 2014 May; 107(5):277-9. PubMed ID: 24709283
[No Abstract] [Full Text] [Related]
16. Novel oral anticoagulants for stroke prevention in atrial fibrillation.
Taylor J
Eur Heart J; 2012 Jun; 33(12):1419-20. PubMed ID: 22880211
[No Abstract] [Full Text] [Related]
17. Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA).
Pengo V; Crippa L; Falanga A; Finazzi G; Marongiu F; Palareti G; Poli D; Testa S; Tiraferri E; Tosetto A; Tripodi A; Manotti C;
Thromb Haemost; 2011 Nov; 106(5):868-76. PubMed ID: 21946939
[TBL] [Abstract][Full Text] [Related]
18. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
Lane DA; Lip GY
Thromb Haemost; 2009 May; 101(5):802-5. PubMed ID: 19404530
[No Abstract] [Full Text] [Related]
19. Dabigatran versus warfarin in patients with atrial fibrillation.
Houston DS; Zarychanski R
N Engl J Med; 2009 Dec; 361(27):2671; author reply 2674-5. PubMed ID: 20042760
[No Abstract] [Full Text] [Related]
20. Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature.
Hohnloser SH; Camm AJ
Europace; 2013 Oct; 15(10):1407-11. PubMed ID: 23954917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
